FIELD: medicine.
SUBSTANCE: fresh morning urine is analysed for an albumin level (H). The values H≥0.15 g/l enable predicting developing recurrent angina following myocardial revascularisation.
EFFECT: method shows no invasiveness and provides higher reliability of the prediction of developing recurrent angina following myocardial revascularisation.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC ETIOLOGY WITHIN A YEAR AFTER CORONARY ARTERY BYPASS GRAFTING | 2022 |
|
RU2801160C1 |
| METHOD OF PREDICTING COURSE OF ISCHEMIC HEART DISEASE AFTER HEART BYPASS | 2007 |
|
RU2363390C1 |
| METHOD FOR DIAGNOSIS OF CORONARY ARTERY STENOSIS RESTENOSIS IN PATIENTS WITH CORONARY HEART DISEASE WITH CHRONIC HEART FAILURE | 2017 |
|
RU2649131C1 |
| METHOD FOR PREDICTING ADVERSE CARDIOVASCULAR EVENTS FOR A PERIOD OF 12 MONTHS IN PATIENTS WITH CHRONIC HEART FAILURE WITH RECURRENCE OF ANGINA AFTER MYOCARDIAL REVASCULARIZATION | 2018 |
|
RU2677611C1 |
| METHOD OF STENT RESTENOSIS FORECAST IN CORONARY ARTERIES AT EARLY STAGES AFTER ENDOVASCULAR MYOCARDIAL REVASCULARISATION | 2007 |
|
RU2349919C1 |
| METHOD OF PREDICTING DEGREE OF RISK OF RESTENOSIS DEVELOPMENT IN CORONARY STENT | 2009 |
|
RU2398507C1 |
| METHOD FOR PREDICTING THE RISK OF THE UNFAVORABLE OUTCOME IN THE PATIENTS SUFFERING ISCHEMIC HEART DISEASE WITHIN THE YEAR FOLLOWING CORONARY ARTERIAL BYPASS | 2019 |
|
RU2704956C1 |
| METHOD OF PREDICTING THE RISK OF DEVELOPING ADVERSE CARDIOVASCULAR OUTCOMES WITHIN A YEAR AFTER PERCUTANEOUS CORONARY INTERVENTIONS WITH STENTING IN PATIENTS WITH STABLE CORONARY HEART DISEASE | 2022 |
|
RU2799146C1 |
| METHOD FOR PREDICTING THE RISK OF ANGINA RECURRENCE IN PATIENTS WITH DIFFUSE LESIONS OF THE CORONARY ARTERIES WHO UNDERWENT CORONARY BYPASS GRAFTING | 2021 |
|
RU2774356C1 |
| METHOD FOR PREDICTION OF AN UNFAVORABLE OUTCOME IN PATIENTS WITH ISCHEMIC HEART DISEASE WHO UNDERWENT AORTOCORONARY BYPASS SURGERY | 2018 |
|
RU2688241C1 |
